Trv GP III, LLC’s Fulcrum Therapeutics Inc Position
Does Trv GP III, LLC own Fulcrum Therapeutics Inc (FULC)? Not currently — the last reported position was 1.96M shares worth $14M in Q4 2022; the fund’s latest 13F (Q4 2023) no longer reports it.
Position Value
$14M
Q4 2022
Shares
1.96M
% of Portfolio
+11.20%
Quarters Held
14
position exited
Position History FULC
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2022 | 1.96M | $14M | +11.20% |
| Q3 2022 | 3.96M | $32M | +14.00% |
| Q2 2022 | 3.96M | $19M | +7.94% |
| Q1 2022 | 3.96M | $94M | +25.43% |
| Q4 2021 | 3.96M | $70M | +17.54% |
| Q3 2021 | 4.96M | $140M | +26.57% |
| Q2 2021 | 5.96M | $62M | +10.91% |
| Q1 2021 | 5.96M | $70M | +8.88% |
| Q4 2020 | 5.96M | $70M | +6.00% |
| Q3 2020 | 5.96M | $47M | +3.97% |
| Q2 2020 | 5.96M | $109M | +15.92% |
| Q1 2020 | 5.96M | $71M | +19.37% |
| Q4 2019 | 5.96M | $99M | +43.81% |
| Q3 2019 | 5.96M | $40M | +22.43% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trv GP III, LLC’s full portfolio or all institutional holders of FULC.